Exenatide Once a Week Versus Placebo As a Potential Disease-Modifying Treatment for People with Parkinson's Disease in the UK: a Phase 3, Multicentre, Double-Blind, Parallel-Group, Randomised, Placebo-Controlled Trial
The Lancet(2025)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined